4//SEC Filing
POWELL MICHAEL 4
Accession 0001209191-21-033818
CIK 0001831828other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 8:23 PM ET
Size
14.1 KB
Accession
0001209191-21-033818
Insider Transaction Report
Form 4
Sofinnova Management X, L.L.C.
10% Owner
Transactions
- Conversion
Series C Preferred Stock
2021-05-18−2,187,504→ 0 total→ Class A Common Stock (2,187,504 underlying) - Purchase
Class A Common Stock
2021-05-18$11.00/sh+727,272$7,999,992→ 2,914,776 total - Conversion
Class A Common Stock
2021-05-18+2,187,504→ 2,187,504 total
HEALY JAMES
10% Owner
Transactions
- Conversion
Class A Common Stock
2021-05-18+2,187,504→ 2,187,504 total - Purchase
Class A Common Stock
2021-05-18$11.00/sh+727,272$7,999,992→ 2,914,776 total - Conversion
Series C Preferred Stock
2021-05-18−2,187,504→ 0 total→ Class A Common Stock (2,187,504 underlying)
Sofinnova Venture Partners X, L.P.
10% Owner
Transactions
- Conversion
Class A Common Stock
2021-05-18+2,187,504→ 2,187,504 total - Conversion
Series C Preferred Stock
2021-05-18−2,187,504→ 0 total→ Class A Common Stock (2,187,504 underlying) - Purchase
Class A Common Stock
2021-05-18$11.00/sh+727,272$7,999,992→ 2,914,776 total
POWELL MICHAEL
10% Owner
Transactions
- Conversion
Class A Common Stock
2021-05-18+2,187,504→ 2,187,504 total - Purchase
Class A Common Stock
2021-05-18$11.00/sh+727,272$7,999,992→ 2,914,776 total - Conversion
Series C Preferred Stock
2021-05-18−2,187,504→ 0 total→ Class A Common Stock (2,187,504 underlying)
Footnotes (2)
- [F1]The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
- [F2]The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the Reporting Persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001202793
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 8:23 PM ET
- Size
- 14.1 KB